Skip to content
FederalSources soughtClosed Federal notice

Equipment: Lonza 4D-Nucleofector® System

National Institutes of Health› National Institutes of Health NICHD Bethesda, MD

Solicitation # 75N98027R00019Updated Nov 12, 2026

This RFP closed on Nov 18, 2026.

The details below are kept for reference. Similar open RFPs are listed first.

Closed

Nov 18, 2026

Responses were due Nov 18, 2026, 11:00 AM EST

Posted
Nov 12, 2026
Closed
Nov 18, 2026

Similar open RFPs

Same NAICS group or Supplies, Equipment & Furniture, nearby first, ranked by score.

Fair

BPA - Laboratory Equipment and Supplies Psc 6640

Department of the Navy · Indian Head, MD

FederalCombined synopsisSmall business set-asideSupplies, Equipment & Furniture+1
Posted Nov 21Due Nov 11, 2028, 12:00 AM EST (in 724 days)Federal notice
Fair

Baxter/Hill-Rom Helux Pro Surgical Light System

National Institutes of Health · Maryland

FederalCombined synopsisSupplies, Equipment & Furniture
Posted Oct 27Due Dec 8, 2026, 2:00 PM EST (in 20 days)Federal notice
Fair

Graphite Furnace Atomic Absorption Spectrometer

National Institute of Standards and Technology · Gaithersburg, MD

FederalSources soughtSupplies, Equipment & Furniture
Posted Oct 28Due Nov 28, 2026, 2:00 PM EST (in 10 days)Federal notice

RFP Detector Scores are informational.How we score →

Summary by RFP Detector

What this RFP is about

National Institutes of Health (National Institutes of Health NICHD), part of the Department of Health and Human Services, posted a sources sought notice titled “Equipment: Lonza 4D-Nucleofector® System” under solicitation number 75N98027R00019. It was posted on Nov 12, 2026. Responses are due Nov 18, 2026, 11:00 AM EST. It is classified under NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and product/service code 6640. No set-aside is listed. The place of performance is Bethesda, Maryland. The listed point of contact is ROBINSON, TINA.

Key facts

Sector
Federal
Notice type
Sources sought
As posted: Sources Sought
PSC
6640
Place of performance
Bethesda, MD
ZIP 20892
Value
Not statedTypical award in this market ≈ $68.5K
Solicitation #
75N98027R00019
Listing
Official federal notice

Score at publication

Score breakdown

Every RFP starts at 50. Each factor adds or subtracts points compared with a typical RFP; unknown data counts as neutral.

This breakdown is from the last scoring while the RFP was open (41, D); the score at publication was 57 (C).

Starts at 50

  • Value−9.6estimated

    No value published. Typical award is about $69K: the median of 1,450 National Institutes of Health contracts over $25K awarded in NAICS 334516, FY24–FY26.

  • Competition & access+1.9measured

    Full and open competition. The largest recipient took 18% of these dollars in FY24–FY26.

  • Issuer & market+3.2measured

    National Institutes of Health obligated $218M on NAICS 334516 across 2,698 contracts in FY24–FY26. 8 other notices from this office in the past 12 months.

  • Time & stage−14.2measured

    Sources sought (market research, not a bid): less than a day to respond (due Nov 18, 2026, 11:00 AM EST). Very tight.

  • Clarity & completeness+3.9estimated

    Documents not listed, named contact with email, 1,042-word description.

  • Freshness+5.9measured

    Posted 5 days ago.

50 + contributions = 57 (C, Limited)

Score trend, last 30 daysScore history: 60, 54, 52, 48, 44, 41

Informational, not advice to bid or not bid. Score version 1.0.0, evaluated Nov 18, 2026.

Requirements & submission

Eligibility · Full and open competition

Full and open competition means the notice states no set-aside: any responsible business can respond, subject to the requirements in the notice.

Not stated in a form we could extract. See the official solicitation for requirements, evaluation criteria and submission steps.

From the official notice

Description

1,042 words

1. Disclaimer THIS IS A SOURCES SOUGHT NOTICE ONLY. This notice is issued solely for information and market research planning purposes. It does not constitute a Request for Quotation (RFQ), Request for Proposal (RFP), or Invitation for Bids (IFB), nor does it restrict the Government to a particular acquisition approach. No contract or purchase order will be awarded from this announcement, and the Government will not reimburse respondents for any costs incurred in preparing a response. 2. Background and Purpose The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions,, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Section of Cell Cycle Regulation, has a requirement for a Brand-Name Lonza 4D-Nucleofector® System consisting of the following: 4D-Nucleofector Core Unit, Part No. AAF-1003B – Quantity (1) EA 4D-Nucleofector X Unit, Part No. AAF-1003X - Quantity (1) EA 3. One-year warranty extension for each unit. Or a functional domestic equivalent, to support ongoing NIH-funded research involving the genetic manipulation of mammalian cells. Because NICHD's ongoing studies rely on previously validated electroporation pulse-code workflows, experimental protocols, and Nucleocuvette™ consumables established on a prior-generation Lonza Nucleofector platform, the Lonza 4D-Nucleofector® System is the primary known platform capable of ensuring experimental reproducibility and data continuity without requiring costly and time-consuming protocol re-optimization or re-validation. The Office of Acquisitions is conducting market research to identify qualified vendors—including small businesses, authorized distributors, and domestic manufacturers—and specifically seeks market information to determine: 1. Authorized Lonza Sources: The availability of Lonza Walkersville, Inc. or authorized distributors/resellers (including small businesses, HUBZone, 8(a), SDVOSB, WOSB, and Small Disadvantaged Businesses under NAICS 334516) capable of supplying new Lonza equipment with full manufacturer-backed warranties. 2. Buy American Act (FAR Part 25) Compliance: The availability of any domestic end products manufactured in the United States capable of meeting all functional, warranty, training, and legacy workflow-continuity requirements outlined in Section 3 without requiring experimental re-validation. 3. Technical Requirements and Salient Characteristics To meet the Government's minimum requirements, the proposed system must satisfy all functional and technical specifications from the Statement of Work alongside the laboratory's workflow-continuity constraints: Core Control Unit: The system shall include a Lonza 4D-Nucleofector® Core Unit (or a domestic equivalent central control unit) capable of controlling and operating advanced electroporation-based transfection protocols. Small-Volume Transfection Module: The system shall include a Lonza 4D-Nucleofector® X Unit (or a domestic equivalent functional module) capable of processing small-volume samples (specifically ranging from 20 µL to 100 µL) and supporting transfection of primary cells and other difficult-to-transfect cell types. Nucleic Acid & Reagent Delivery: The system shall support delivery of plasmid DNA, RNA, siRNA, CRISPR/Cas9 reagents, and other nucleic acid-based materials into mammalian cells. Optimized Transfection Performance: The system shall provide optimized electroporation programs designed to maximize transfection efficiency while maintaining high post-transfection cell viability. Sensitive Cell Applications: The system shall support research applications involving primary cells, stem cells, immune cells, and other sensitive cell populations that are not efficiently transfected using conventional lipid-based methods. Software and Protocols: The system shall include manufacturer-provided software and protocols necessary for operation of the instrument. Warranty Coverage: The system shall include a minimum one-year manufacturer warranty and one-year warranty extension coverage for both the Core Unit and X Unit (two years total coverage). Warranty coverage shall begin upon Government acceptance of the equipment and continue in accordance with the manufacturer's warranty terms. Consumable & Legacy Protocol Continuity: If proposing Lonza equipment, the system shall be 100% compatible with commercially available Lonza Nucleofector® reagents, Nucleocuvette™ consumables, and existing pulse-code workflows previously developed and validated on a prior-generation Lonza Nucleofector platform. If proposing a domestic alternative, the vendor must demonstrate that its system and consumables achieve equivalent transfection efficiency and post-transfection cell viability across NICHD's existing mammalian cell workflows without requiring protocol re-optimization or experimental re-validation. Delivery, Installation, and Training: Equipment must be delivered to NIH Bethesda (Building 49) and installed, with on-site or virtual user training for up to five (5) NIH personnel completed within 30 days of installation (covering system operation, software functionality, routine maintenance, and basic troubleshooting). All delivery, installation, and training shall be completed within the 12-month period of performance from award. 4. Capability Statement Submission Instructions Interested organizations that believe they can meet all requirements outlined in Section 3 are invited to submit a tailored Capability Statement (no more than 5 pages) containing the following information: 1. Company Profile: Organization name, mailing address, primary Point of Contact (name, title, email, and telephone number), (see the official solicitation) Unique Entity ID (UEI), and CAGE code. 2. Business Size & Socioeconomic Status: Business size under NAICS 334516 (1,000-employee size standard) and applicable socioeconomic designations (e.g., Small Business, Woman-Owned, Veteran-Owned, Service-Disabled Veteran-Owned, HUBZone, 8(a)). 3. Contract Vehicles: Identification of any existing federal contract vehicles held by the vendor through which this equipment can be ordered (e.g., GSA Multiple Award Schedule), or confirmation of open-market availability. 4. Country of Origin (COO): Explicit identification of the manufacturing country of origin for all proposed hardware components and confirmation of whether the system qualifies as a domestic end product under the Buy American Act (FAR Part 25). 5. Technical Capability & Authorization: Product brochures, technical specifications, and catalog numbers demonstrating compliance with every requirement in Section 3. If proposing Lonza equipment: Documentation confirming status as an Authorized Distributor/Reseller eligible to provide new equipment and manufacturer-backed warranties. If proposing a domestic alternative: Technical evidence proving equivalent transfection performance and workflow continuity with existing NICHD mammalian cell protocols without requiring experimental re-validation. 6. Rough Order of Magnitude (ROM) Pricing (Optional): Non-binding budgetary pricing estimate for market research purposes. 5. Place of Performance: NIH, 9000 Rockville Pike, Bethesda, MD 20892 6. Submission Deadline and Contact Information Please submit electronic Capability Statements in PDF or Microsoft Word format via email to Tina Robinson at robinsti@mail.nih.gov no later than November 18, 2026, at 11:00 AM EST. Telephone inquiries will not be accepted. Capability Statements must reference Notice Number 75N98027R00019. Email submissions and any questions must be sent to robinsti@mail.nih.gov and include Notice Number 75N98027R00019 in the subject line. Capability Statements and attachments will not be returned to the sender. This synopsis is for information and planning purposes only and shall not be construed as a commitment by the Government, nor will the Government pay for information solicited.

Documents

No documents are listed for this notice.

Contacts

Points of contact as published on the notice.

Timeline & history

  1. Sources Sought posted

  2. Responses were due

Federal award history

Market context

National Institutes of Health · NAICS 334516 · FY24–FY26

Typical award (over $25K)
$68.5K
Contracts awarded
2,698
Total obligated
$218.1M
Award size, National Institutes of Health · NAICS 334516 contracts, FY24–FY26 (log scale)
P25 $17.0KMedian $28.0KP75 $74.0KP90 $210.3K

Largest recipients in this market

  • ILLUMINA, INC.$38.3M18%
  • GOVERNMENT SCIENTIFIC SOURCE INC$21.6M10%
  • 10X GENOMICS, INC.$10.6M5%

Recipients of past awards in this market, not the incumbent of this RFP.

View as table
Fiscal yearObligated ($)
FY2022202,524,389.77
FY2023155,463,927.9
FY202496,911,421.94
FY202550,019,013.25
FY202671,157,131.24

Federal contract award records, award types A–D, FY24–FY26. Updated Nov 13, 2026.

More from National Institutes of Health

69 open RFPs from this issuer and its offices.

Limited

CSS - Spectra-Physics InSight X3 Dual Laser System

National Institutes of Health

FederalCombined synopsisSupplies, Equipment & Furniture
Posted Nov 6Due Nov 20, 2026, 11:00 AM EST (in 45 h)Federal notice

RFP Detector Scores are informational.How we score →

About this notice

Official federal notice. Updated Nov 12, 2026.

Official solicitation:Sign in free to open the official solicitation

RFP Detector is an independent service and is not affiliated with any government agency. Scores are informational.

RFP Detector is not affiliated with the organization that issued this RFP. Always rely on the official notice and confirm every date and requirement with the issuer.